C-Seal: Colorectal anastomosis proteced by a biodegradable drain fixed to the anastomosis by a circular stapler: A Multi-Center Randomized Controlled Trial.

Trial Overview

AcronymC-Seal
NumberNTR3080
Protocol Linkhttp://bmcsurg.biomedcentral.com/articles/10.1186/1471-2482-12-23
Public Trial Registry Linkhttp://www.trialregister.nl/trialreg/admin/rctview.asp?TC=3080
StatusClosed
CategoryColorectal Cancer - All
Treatment CourseSurgery

Trial Description

The C-seal trial is a prospective multi-center randomized controlled trial with primary endpoint, anastomotic leakage leading to re-intervention within 30 days after operation. In this trial 616 patients will be randomized to the C-seal or control group (1:1), stratified by center, anastomotic height (proximal or distal of peritoneal reflection) and the intention to create a temporary deviating ostomy. Interim analyses are planned after 50% and 75% of patient inclusion.

Chief Investigator

K. Havenga
MD, PhD
Profile Link

Lead Centre

University Medical Center Groningen
Hanzeplein 1
Groningen
9713
Netherlands
Website

Additional Information

Full Research Summary